International Isotopes Inc (OTCMKTS:INIS) Stock Corrects After Recent Gains

The appointment of a new executive is almost always seen as a major development for any company and often brings the company on to the radars of investors. Yesterday it was International Isotopes Inc (OTCMKTS:INIS) which came into the news cycle after it announced that it had appointed a new President in the form of ShaheBagerdjian. The appointment went into effect immediately.

Trading Data

On Monday, INIS stock lost 14.55% to $0.0470 with 19.12K shares, compared to its average volume 52.60K shares. The stock moved within a range of $0.0470 – 0.0525 after opening trade at $0.0525.

International Isotopes Inc. Announces The Appointment Of Shahe Bagerdjian As President

Bagerdjian came into this role after having served at Global Medical Solutions, a company which is one of leading manufacturers and providers of diagnostic imaging and radiopharmaceuticals products for nuclear medicine applications.

During his tenure at Global Medical Solutions Bagerdjian had been in charge for the implantation of both the long term and short term strategies at the company. He had also been in charge of overseeing the day to day operations that were meant to execute those strategies.

He had been at the company for a decade and had eventually been responsible for as many as 350 employees spread across 11 nations. Under his leadership, Global Medical Solutions had grown to be one of the biggest companies in Southeast Asia in its industry. The Chief Excutive Officer of Bagerdjianz International Isotopes Steve Laflin noted that everyone at the company was pleased at the appointment.